Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 401-450 of 6028 result(s).
CYDY CytoDyn Inc
11/04/2024 11:02:28 PM
A surrogate endpoint.... The FDA in (3)
CYDY CytoDyn Inc
11/04/2024 10:47:37 PM
For the Alzheimer's trial you menti (8)
CYDY CytoDyn Inc
11/04/2024 7:41:06 PM
Those numbers suggest an average of (6)
CYDY CytoDyn Inc
11/04/2024 7:37:50 PM
If I remember right, others also me (5)
CYDY CytoDyn Inc
11/04/2024 7:32:30 PM
I might be off target here...it cer (9)
CYDY CytoDyn Inc
11/04/2024 7:26:29 PM
I haven't seen any direct results f (6)
CYDY CytoDyn Inc
11/04/2024 5:59:15 PM
Typically, how long are these trial (8)
CYDY CytoDyn Inc
11/04/2024 5:20:21 PM
Can you explain in layman's terms w (23)
CYDY CytoDyn Inc
11/04/2024 4:58:18 PM
“There may be breakout news” Wh (14)
CYDY CytoDyn Inc
11/04/2024 4:55:39 PM
He's/She's a Short...dressed with D (13)
CYDY CytoDyn Inc
11/04/2024 4:53:31 PM
While these drugs (GLP-1 agonists) (12)
CYDY CytoDyn Inc
11/04/2024 3:35:56 PM
Why not the next 3-4 months?? I wou (11)
CYDY CytoDyn Inc
11/01/2024 1:13:25 AM
AVXL had good results for the Alzhe (22)
CYDY CytoDyn Inc
10/30/2024 11:47:23 PM
There is no petition for Right to T (8)
CYDY CytoDyn Inc
10/30/2024 6:12:00 PM
With what drug would you think lero (7)
CYDY CytoDyn Inc
10/30/2024 10:23:39 AM
Dr. Palmer is leading new studies t (11)
CYDY CytoDyn Inc
10/30/2024 10:13:33 AM
I don’t know whether any of these (7)
CYDY CytoDyn Inc
10/30/2024 10:09:10 AM
“And a GLP-1 agonist”- talk abo (9)
CYDY CytoDyn Inc
10/30/2024 10:04:15 AM
I saw that Neuvivo recently submit (13)
CYDY CytoDyn Inc
10/30/2024 8:57:56 AM
Dr. Palmer will work with the CytoD (19)
CYDY CytoDyn Inc
10/30/2024 8:52:30 AM
Coya yesterday reported their low d (7)
CYDY CytoDyn Inc
10/30/2024 1:14:13 AM
I am not aware of what the Neurorad (8)
CYDY CytoDyn Inc
10/30/2024 1:02:25 AM
And here is the research I found a (9)
CYDY CytoDyn Inc
10/30/2024 12:58:02 AM
Does anyone know of any MS trials f (8)
CYDY CytoDyn Inc
10/29/2024 3:40:46 PM
Where's the CRC protocol? Where are (12)
CYDY CytoDyn Inc
10/29/2024 3:32:51 PM
Ohm - do you discount the possibili (12)
CYDY CytoDyn Inc
10/29/2024 3:27:29 PM
Aren't you projecting on things not (9)
CYDY CytoDyn Inc
10/29/2024 9:10:45 AM
The case for an Alzheimer's trial - (27)
CYDY CytoDyn Inc
10/29/2024 8:48:28 AM
When investing you have to do deep (27)
CYDY CytoDyn Inc
10/29/2024 7:38:42 AM
Someone asked me about Multiple Scl (21)
CYDY CytoDyn Inc
10/29/2024 6:31:15 AM
Good gravy. I’ll have whatever it (6)
CYDY CytoDyn Inc
10/29/2024 6:27:15 AM
Hopefully this results in a convict (4)
CYDY CytoDyn Inc
10/21/2024 3:47:53 PM
From Reddit, this is the first time (6)
CYDY CytoDyn Inc
10/20/2024 4:22:25 AM
If I hadn't gone down the deep, dee (18)
CYDY CytoDyn Inc
10/20/2024 4:06:27 AM
By mentioning Adjunct therapy, I’ (9)
CYDY CytoDyn Inc
10/20/2024 3:58:23 AM
It certainly could be and that’s (6)
CYDY CytoDyn Inc
10/20/2024 3:50:20 AM
Beating placebo in SAE on a 28/28 a (11)
CYDY CytoDyn Inc
10/20/2024 3:34:05 AM
So my question to any/all who might (6)
CYDY CytoDyn Inc
10/20/2024 3:27:53 AM
Groundbreaking clinical trial achie (15)
CYDY CytoDyn Inc
10/20/2024 2:35:45 AM
yes, that gene deletion means CCR5 (12)
CYDY CytoDyn Inc
10/20/2024 2:28:38 AM
I know someone who was put on Leron (20)
CYDY CytoDyn Inc
10/20/2024 1:18:26 AM
Being they didnt have the exclusion (15)
CYDY CytoDyn Inc
10/19/2024 11:02:49 AM
Long Covid results -- 4/2024. What (18)
CYDY CytoDyn Inc
10/18/2024 3:14:02 AM
Brain inflammation. Brain receptors (20)
CYDY CytoDyn Inc
10/17/2024 2:04:54 PM
Someone sent me a link to a new sca (23)
CYDY CytoDyn Inc
10/16/2024 5:43:14 AM
Possibly but a decrease in log of 1 (22)
CYDY CytoDyn Inc
10/14/2024 3:32:15 AM
The Amarex settlement and the warra (11)
CYDY CytoDyn Inc
10/14/2024 2:12:47 AM
I'm talking about didn't close shop (12)
CYDY CytoDyn Inc
10/14/2024 2:10:30 AM
Rhesus macaques age at a rate of ab (6)
CYDY CytoDyn Inc
10/14/2024 2:08:26 AM
Foscarnet and Ibalizumab Ibalizumab (9)
Go to page:
  • << First
  • < Previous
  • 8
  • 9
  • Next >

Recent Articles

  • Social Security's Urgent Future: Navigating Potential Benefit Cuts
  • Chamath Palihapitiya Challenges College Norms in Today’s Economy
  • Join the SelectQuote Class Action: Protect Your Investment Now
  • Class Action Lawsuit Against KinderCare: Key Details for Investors
  • Investigation of Apple Inc. by Kahn Swick & Foti LLC Revealed
  • Explore SETT NOIR: A Stellar Sterling Silver Jewelry Line
  • Neogen Corporation Faces Class Action: Key Information for Investors
  • Investors Alert: Important Updates on Hims & Hers Health Cases
  • Key Developments in Flywire Corporation's Shareholder Lawsuit
  • Investors Alert: Lead Plaintiff Deadline in SOC Class Action
  • Justice for Noe Rodriguez: Press Conference Highlights
  • Trump Administration's Week 30: Achievements and Announcements
  • Trump and Putin's Recent Summit: Hopes and Challenges Ahead
  • Kokomo Solutions Investigated for Student Data Security Breach
  • America’s Resurgence: The Highlights of Week 30 Under Trump
  • Exploring OpenAI's Partnership with Federal Agencies for AI Access
  • Anniversary Celebration: DermRays Unveils New Laser Innovations
  • DermRays Marks a Milestone with a New Laser Device Launch
  • Prime Drink Group Updates on MCTO and Successful Fundraising
  • A.I.S. Resources Updates on Default Status and Progress Report
  • Investors Unite: Opportunities from Charter Communications' Case
  • Investors Explore Legal Action Against Fiserv, Inc. for Fraud
  • Western Asset Mutual Fund Investors Can Take Legal Action Now
  • Grand Canyon University's Legal Victory Marks a New Chapter
  • HF Sinclair Finalizes Tender Offer and Debt Securities Update
  • Transforming $100 into $452: The Texas Roadhouse Journey
  • Rocket Companies Provides Insights on Exchange Offers and Consents
  • Rocket Companies Tenders for Nationstar Mortgage Bonds
  • Transforming Car Purchases: Cryptocurrency and Luxury Vehicles
  • Transforming $1000 in US Foods Holdings into Wealth Over Time
  • Celebrating Two Decades of Innovation with Five Star Solutions
  • Novelis' Tender Offer Results for Senior Notes Announced
  • RYVYL Transitions Leadership as It Enhances Crypto Focus
  • How a $100 Investment in UMB Financial Has Grown Over Time
  • The Incredible Growth of Baidu: A 20-Year Investment Journey
  • Sky Quarry Inc. Reports Impressive Growth in Q2 Financials
  • Orthodox Jewish Community Protests Israeli Draft Policies
  • Sky Quarry's Latest Financial Performance Indicates Growth Potential
  • IronOrbit Celebrates Three Years in Gartner Magic Quadrant
  • The Surprising Growth of Ciena: A 15-Year Journey
  • NorthStrive Companies Inc. Celebrates Two Major Acquisitions
  • Marwest Apartment REIT Confirms Monthly Payouts for Unitholders
  • Discover the New Belleza Community with Model Homes in California
  • Exploring the Impressive Growth of Advanced Micro Devices
  • FuelPositive Clarifies Key Statement on System Delivery and Activation
  • Quest Diagnostics Highlights Strategy at Global Healthcare Event
  • PayLaterr Partners with Experian to Boost Data-Driven Insights
  • Richmond American Homes Begins Pre-sales of New Community
  • Support for Striking Technicians: Rally for Equal Pay Focus
  • Understanding Eli Lilly Inc's Valuation With P/E Metrics
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site